SCHEMBL2910374

SCHEMBL2910374

O=C(O)N1CCN(C(c2ccc(-c3cccc(F)c3)cc2)c2c[nH]nc2-c2ccco2)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
LMNA P02545 5/20 0.41
USP2 O75604 3/20 0.41
KDM4E B2RXH2 2/20 0.41
NPC1 O15118 1/20 0.41
GAA P10253 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 3/20 0.36
MAPT P10636 2/20 0.35
TP53 P04637 1/20 0.35
RECQL P46063 1/20 0.35
KMT2A Q03164 1/20 0.35
PIK3R1 P27986 1/20 0.34
PIK3CA P42336 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
TSHR P16473 4/20 0.33
CACNA2D1 P54289 1/20 0.33
CACNA1B Q00975 1/20 0.33
CACNB1 Q02641 1/20 0.33
CACNA1C Q13936 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2905980 0.92 ALDH1A1 (0.42) ALDH1A1LMNAUSP2KDM4ENPC1
SCHEMBL2904791 0.89 CYP3A4 (0.42) ALDH1A1LMNAUSP2KDM4ENPC1
SCHEMBL2902613 0.87 PIK3R1 (0.37) ALDH1A1LMNAKDM4EGAANPSR1
SCHEMBL2903067 0.87 OPRD1 (0.37) KMT2APIK3R1PIK3CA
SCHEMBL2907051 0.86 ALDH1A1 (0.41) ALDH1A1LMNAUSP2KDM4ENPC1
SCHEMBL2905283 0.85 ALDH1A1 (0.52) ALDH1A1LMNAUSP2KDM4ENPC1
SCHEMBL2902229 0.85 SMN1; SMN2 (0.47) ALDH1A1LMNAUSP2KDM4ENPC1
SCHEMBL2902357 0.85 HRH3 (0.37) ALDH1A1LMNAUSP2KDM4ENPC1
Morpholine SCHEMBL2905731 0.84 OPRD1 (0.35) LMNAMAPTTP53PIK3R1PIK3CA
SCHEMBL2908848 0.83 LRRK2 (0.36) LMNAMAPTPIK3R1PIK3CAMCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1611107-B1 1,3,4-SUBSTITUTED PYRAZOLES FOR USE AS 5-HT RECEPTOR ANTAGONISTS IN THE TREATMENT OF PSYCHOSES AND NEUROLOGICAL DISORDERS MERCK PATENT GMBH (DE) 2010-08-18 EP claimed